On Sep 9, 2021 RareCyte closed a Series G round and raised $24,000,000 from 5AM Ventures, Agilent Technologies, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, Logos […]
HRA Pharma acquired by Perrigo
Sep 8, 2021 Perrigo has entered into an agreement to acquire HRA Pharma in a $2,100,000,000 deal. Perrigo based at Dublin, Dublin, Ireland. “To make […]
Post-IPO Equity – Bluebird Bio
On Sep 8, 2021 Bluebird Bio closed a Post-IPO Equity round and raised $75,000,000 from investors, featuring lead investors . About the company: Bluebird Bio […]
Debt Financing – Spiber
On Sep 8, 2021 Spiber closed a Debt Financing round and raised ¥10,000,000,000 from MUFG Bank, featuring lead investors MUFG Bank. About the company: Spiber […]
Venture Round – Haemalogix
On Sep 8, 2021 Haemalogix closed a Venture – Series Unknown round and raised A$10,000,000 from Platinum Asset Management, featuring lead investors Platinum Asset Management. […]
Series A – Replicate Bioscience
On Sep 8, 2021 Replicate Bioscience closed a Series A round and raised $40,000,000 from Apple Tree Partners, featuring lead investors Apple Tree Partners. About […]
Series B – Attralus
On Sep 8, 2021 Attralus closed a Series B round and raised $116,000,000 from Janus Henderson Investors, Logos Capital, Redmile Group, Samsara BioCapital, Sarissa Capital […]
Series B – PetMedix
On Sep 8, 2021 PetMedix closed a Series B round and raised £27,000,000 from Cambridge Innovation Capital, Digitalis Ventures, Kyoritsu Corporation, Parkwalk Advisors, Tencent, featuring […]
Series B – ADARx Pharmaceuticals
On Sep 8, 2021 ADARx Pharmaceuticals closed a Series B round and raised $75,000,000 from Lilly Asia Ventures, OrbiMed, Sirona Capital, SR One, featuring lead […]
Private Equity Round – Spiber
On Sep 8, 2021 Spiber closed a Private Equity round and raised ¥24,400,000,000 from Baillie Gifford, Cool Japan Fund, Fidelity International, Satake Chemical Machinery, The […]
